Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Recent advances in molecular biology of thyroid cancer and their clinical implications Xing MOtolaryngol Clin North Am 2008[Dec]; 41 (6): 1135-46, ixThyroid cancer is the most common endocrine malignancy. With a rapidly rising incidence in recent years, novel efficient management strategies are increasingly needed for this cancer. Remarkable advances have occurred in understanding several major biologic areas of thyroid cancer, including the molecular alterations for the loss of radioiodine avidity of thyroid cancer, the pathogenic role of the MAP kinase and PI3K/Akt pathways and their related genetic alterations, and the aberrant methylation of functionally important genes in thyroid tumorigenesis and pathogenesis. These exciting advances provide unprecedented opportunities for the development of molecular-based novel diagnostic, prognostic, and therapeutic strategies for thyroid cancer.|DNA Methylation/physiology[MESH]|Gene Expression Regulation, Neoplastic[MESH]|Humans[MESH]|Methylation[MESH]|Mitogen-Activated Protein Kinases/genetics[MESH]|Oncogene Protein v-akt/genetics[MESH]|Proto-Oncogene Proteins B-raf/genetics[MESH]|Signal Transduction/physiology[MESH]|Thyroid Neoplasms/*genetics/metabolism[MESH] |
